Cicatricial pemphigoid with circulating autoantibodies to β4 integrin, bullous pemphigoid 180 and bullous pemphigoid 230

British Journal of Dermatology

Volumn 145, Issue 6, 2001, Pages 998-1004

  Leverkus, Martin ^a   Bhol, K ^a   Hirako, Y ^a   Pas, H ^a   Sitaru, C ^a   Baier, G ^a   Brocker E B ^a   Jonkman, M F ^a   Ahmed, A R ^a   Zillikens, D ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

BP180; BP230; Cicatricial pemphigoid; 4 integrin

Indexed keywords

AUTOANTIBODY; BETA4 INTEGRIN; COLLAGEN TYPE 7; CYCLOPHOSPHAMIDE; DEXAMETHASONE; FLUCONAZOLE; PROTEIN SUBUNIT;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DERMOEPIDERMAL JUNCTION; DISEASE ACTIVITY; DISEASE COURSE; DRUG PULSE THERAPY; EROSION; FEMALE; GENETIC TRANSFECTION; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOFLUORESCENCE MICROSCOPY; KERATINOCYTE; LEUKOPENIA; MOUTH MUCOSA; MUCOUS MEMBRANE PEMPHIGOID; PRIORITY JOURNAL; SUPERNATANT; TREATMENT OUTCOME;

AGED; ANTIGENS, CD; AUTOANTIBODIES; AUTOANTIGENS; CARRIER PROTEINS; COLLAGEN; CYTOSKELETAL PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOBLOTTING; INTEGRIN BETA4; MALE; NERVE TISSUE PROTEINS; NON-FIBRILLAR COLLAGENS; PEMPHIGOID, BENIGN MUCOUS MEMBRANE;

EID: 0035725456     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2001.04543.x     Document Type: Article

References (37)

1. Cicatricial pemphigoid
2. Pemphigoid. Bullous and cicatricial
3. Cicatricial pemphigoid
4. Mucous membrane pemphigoid: A dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease
5. Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extra-cellular domain
6. Anti-epiligrin cicatricial pemphigoid. A subepithelial bullous disorder
7. Antiepiligrin cicatricial pemphigoid: An underdiagnosed entity within the spectrum of scarring autoimmune subepidermal bullous diseases?
8. Mucosal morbidity in patients with epidermolysis bullosa acquisita
9. Ocular cicatricial pemphigoid antigen: Partial sequence and biochemical characterization
10. Hemidesmosome formation is initiated by the beta4 integrin subunit, requires complex formation of beta4 and HD1/plectin, and involves a direct interaction between beta4 and the bullous pemphigoid antigen 180
11. Biology and function of hemidesmosomes
12. Hereditary skin diseases of hemidesmosomes
13. The role of antibody to human beta4 integrin in conjunctival basement membrane separation: Possible in vitro model for ocular cicatricial pemphigoid
14. The autoantibodies to alpha6beta4 integrin of patients affected by ocular cicatricial pemphigoid recognize predominantly epitopes within the large cytoplasmic domain of human beta4
15. Dexamethasone-cyclophosphamide pulse therapy in bullous autoimmune dermatoses
16. Cicatricial pemphigoid - A therapeutic problem
17. Cicatricial pemphigoid
18. A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone
19. The use of skin substrates deficient in basement membrane molecules for the diagnosis of subepidermal autoimmune bullous disease
20. Biphasic effects of 12-O-tetradecanoylphorbol-13-acetate on the cell morphology of low calcium-grown human epidermal carcinoma cells: Involvement of translocation and down regulation of protein kinase C
21. Cleavage of BP180, a 180-kDa bullous pemphigoid antigen, yields a 120-kDa collagenous extracellular polypeptide
22. Identification of a new hemidesmosomal protein, HD1: A major, high molecular mass component of isolated hemidesmosomes
23. Demonstration of the molecular shape of BP180, a 180-kDa bullous pemphigoid antigen and its potential for trimer formation
24. Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP180
25. Bullous pemphigoid and linear IgA dermatosis sera recognize a similar 120-kDa keratinocyte collagenous glycoprotein with antigenic cross-reactivity to BP180
26. Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies
27. The beta 4 subunit cytoplasmic domain mediates the interaction of alpha 6 beta 4 integrin with the cytoskeleton of hemidesmosomes
28. A recombinant tail-less integrin beta 4 subunit disrupts hemidesmosomes, but does not suppress alpha 6 beta 4-mediated cell adhesion to laminins
29. Analysis of antigens targeted by circulating IgG and IgA autoantibodies in 50 patients with cicatricial pemphigoid
30. The immunoglobulin A antibody response in clinical subsets of mucous membrane pemphigoid
31. New and emerging therapies in the treatment of blistering diseases
32. In vitro organ culture model for mucous membrane pemphigoid
33. Bullous skin diseases
34. Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: A preliminary study
35. Role of cyclophosphamide and high dose steroid in ocular cicatricial pemphigoid
36. Cicatricial pemphigoid successfully treated with pulse intravenous cyclophosphamide